Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 2276
TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359870BDBM359870(US9822120, Compound 25)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359871BDBM359871(US9822120, Compound 26)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359868BDBM359868(US9822120, Compound 22)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359869BDBM359869(US9822120, Compound 24)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359874BDBM359874(US9822120, Compound 30)
Affinity DataEC50: <100nMAssay Description:Method B: hBTK kinase is diluted in buffer and all compounds were prepared to 50× final assay concentration in 100% DMSO. This working stock of the c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359875BDBM359875(US9822120, Compound 31)
Affinity DataEC50: <100nMAssay Description:Method B: hBTK kinase is diluted in buffer and all compounds were prepared to 50× final assay concentration in 100% DMSO. This working stock of the c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359872BDBM359872(US9822120, Compound 27)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359873BDBM359873(US9822120, Compound 29)
Affinity DataEC50: <100nMAssay Description:Method B: hBTK kinase is diluted in buffer and all compounds were prepared to 50× final assay concentration in 100% DMSO. This working stock of the c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359862BDBM359862(US9822120, Compound 16)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359863BDBM359863(US9822120, Compound 17)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359860BDBM359860(US9822120, Compound 14)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359861BDBM359861(US9822120, Compound 15)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359866BDBM359866(US9822120, Compound 20)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359867BDBM359867(US9822120, Compound 21)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359864BDBM359864(US9822120, Compound 18)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359865BDBM359865(US9822120, Compound 19)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359854BDBM359854(US9822120, Compound 8)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359855BDBM359855(US9822120, Compound 9)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359852BDBM359852(US9822120, Compound 6)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359853BDBM359853(US9822120, Compound 7)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359858BDBM359858(US9822120, Compound 12)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359859BDBM359859(US9822120, Compound 13)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359856BDBM359856(US9822120, Compound 10)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359857BDBM359857(US9822120, Compound 11)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359878BDBM359878(US9822120, Compound 35)
Affinity DataEC50: <100nMAssay Description:Method B: hBTK kinase is diluted in buffer and all compounds were prepared to 50× final assay concentration in 100% DMSO. This working stock of the c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359847BDBM359847(US9822120, Compound 1)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359876BDBM359876(US9822120, Compound 33)
Affinity DataEC50: <100nMAssay Description:Method B: hBTK kinase is diluted in buffer and all compounds were prepared to 50× final assay concentration in 100% DMSO. This working stock of the c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359877BDBM359877(US9822120, Compound 34)
Affinity DataEC50: <100nMAssay Description:Method B: hBTK kinase is diluted in buffer and all compounds were prepared to 50× final assay concentration in 100% DMSO. This working stock of the c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359850BDBM359850(US9822120, Compound 4)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359851BDBM359851(US9822120, Compound 5)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359848BDBM359848(US9822120, Compound 2)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359849BDBM359849(US9822120, Compound 3)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359870BDBM359870(US9822120, Compound 25)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359871BDBM359871(US9822120, Compound 26)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359868BDBM359868(US9822120, Compound 22)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359869BDBM359869(US9822120, Compound 24)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359874BDBM359874(US9822120, Compound 30)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359875BDBM359875(US9822120, Compound 31)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359873BDBM359873(US9822120, Compound 29)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359862BDBM359862(US9822120, Compound 16)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359863BDBM359863(US9822120, Compound 17)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359860BDBM359860(US9822120, Compound 14)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359861BDBM359861(US9822120, Compound 15)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359866BDBM359866(US9822120, Compound 20)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359867BDBM359867(US9822120, Compound 21)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359865BDBM359865(US9822120, Compound 19)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359878BDBM359878(US9822120, Compound 35)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359876BDBM359876(US9822120, Compound 33)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359877BDBM359877(US9822120, Compound 34)
Affinity DataEC50: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandChemical structure of BindingDB Monomer ID 359854BDBM359854(US9822120, Compound 8)
Affinity DataKi: <100nMAssay Description:Method A: Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: